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Abstract
Introduction: The COVID-19 pandemic has posed several challenges to clinical laboratories across the globe. Amidst the outbreak, errors occurring 
in the preanalytical phase of sample collection, transport and processing, can further lead to undesirable clinical consequences. Thus, this study was 
designed with the following objectives: (i) to determine and compare the blood specimen rejection rate of a clinical laboratory and (ii) to characteri-
se and compare the types of preanalytical errors between the pre-pandemic and the pandemic phases.
Materials and methods: This retrospective study was carried out in a trauma-care hospital, presently converted to COVID-19 care centre. Data was 
collected from (i) pre-pandemic phase: 1st October 2019 to 23rd March 2020 and (ii) pandemic phase: 24th March to 31st October 2020. Blood speci-
men rejection rate was calculated as the proportion of blood collection tubes with preanalytical errors out of the total number received, expressed 
as percentage. 
Results: Total of 107,716 blood specimens were screened of which 43,396 (40.3%) were received during the pandemic. The blood specimen re-
jection rate during the pandemic was significantly higher than the pre-pandemic phase (3.0% versus 1.1%; P < 0.001). Clotted samples were the 
commonest source of preanalytical errors in both phases. There was a significant increase in the improperly labelled samples (P < 0.001) and sam-
ples with insufficient volume (P < 0.001), whereas, a significant decline in samples with inadequate sample-anticoagulant ratio and haemolysed 
samples (P < 0.001).
Conclusion: In the ongoing pandemic, preanalytical errors and resultant blood specimen rejection rate in the clinical laboratory have significantly 
increased due to changed logistics. The study highlights the need for corrective steps at various levels to reduce preanalytical errors in order to op-
timise patient care and resource utilisation. 
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Introduction
Ever since the pandemic was declared on 11th 
March, 2020 by the World Health Organisation, it 
has posed several challenges on various fronts. 
The clinical laboratories across the globe have 
adapted to maintain the highest standards of pa-
tient care despite the COVID-19 pandemic. The im-
precision and inaccuracies in results occurring due 
to preanalytical errors have always been a major 
cause of concern for diagnostic laboratories (1-4). 
Preanalytical errors range between 46‐68% out of 
all errors occurring in the total testing process (5). 
The preanalytical errors result in specimen rejec-
tion due to which another blood specimen has to 
be collected and sent again to the laboratory. This 
results in a significant delay in receiving laboratory 
test results which often compromises patient care, 
especially for patients in intensive care units. The 
cost burden due to preanalytical errors has been 
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reported to constitute 0.2-1.2% of the total hospi-
tal operating costs (6). 
During the ongoing pandemic, the healthcare 
professionals are required to wear personal pro-
tective equipment (PPE) while taking care of the 
patients. Furthermore, the specimen collection 
and transport logistics are also different from the 
pre-pandemic times (7,8). The impact of these 
changed protocols for specimen collection, pack-
aging and transport on the frequency of preana-
lytical errors is unknown. We hypothesised that 
during this ongoing pandemic, the rate and char-
acteristics of preanalytical errors is likely to differ 
from the pre-pandemic times. Basic knowledge of 
these differences can help to focus on strategies to 
prevent preanalytical errors during future pan-
demics and in similar exigencies. Therefore, we de-
signed this study with the following objectives: (i) 
to determine and to compare the blood specimen 
rejection rate of our clinical laboratory between 
the pre-pandemic and the pandemic phases, and 
(ii) to characterise and to compare the type of pre-
analytical errors between the pre-pandemic and 
the pandemic phases. 
Materials and methods
Materials
This retrospective observational study was con-
ducted in the clinical laboratory of a tertiary care 
hospital caring for trauma patients in South Asia. 
The centre was declared as a COVID-19 care centre 
on 23rd March 2020 to take care of the anticipated 
rise in the cases. The central laboratory of this 250 
bedded hospital receives blood samples for com-
plete blood count, coagulation profile, biochemi-
cal examination, immunology, along with samples 
for urinalysis and histopathology and operates 
24x7 throughout the year. The laboratory process 
is monitored daily by internal quality controls. The 
phlebotomies of the hospitalised patients are per-
formed either by treating physicians or nurses. 
For the study, data was retrospectively collected 
for the period from October 2019 to October 2020. 
The study period was divided into: (i) the pre-pan-
demic phase from 1st October 2019 to 23rd March 
2020 and (ii) the pandemic phase from 24th March 
to 31st October 2020. 
All specimens received in the clinical laboratory 
during the study period were included. Laborato-
ry records for the specimens rejected due to pre-
analytical errors were accessed for the study peri-
od and analysed. The sample rejection rate was 
calculated as the proportion of blood samples 
with preanalytical errors out of the total number 
of blood specimens received and was expressed 
as a percentage. 
Methods
The vacutainer blood collection tubes (BCT) with 
potassium salt of ethylenediaminetetraacetic acid 
(EDTA) and sodium citrate are used for complete 
blood count and coagulation profile, respectively. 
The serum separator tube with silica clot activator, 
polymer gel, silicone-coated interior (Becton Dick-
inson, Franklin Lakes, USA) are used for biochemi-
cal and immunological tests. During the current 
pandemic, the specimens collected from patients 
in these barcoded blood collection tubes, are be-
ing manually delivered to the laboratory by a hos-
pital attendant in contrast to the pneumatic 
shoots which were used in the pre-pandemic 
phase. 
Currently, all specimens received in the clinical lab-
oratory are processed in class 2 biological safety 
cabinet by a medical technologist after wearing 
PPE. The BCT are at first treated with ultraviolet 
rays for five minutes, after which the outer surface 
of the BCT are wiped with 0.1% hypochlorite solu-
tion using tissue paper and kept for five minutes 
before further processing. All the BCT received in 
the laboratory are visually screened by the medi-
cal technologist for the following seven quality in-
dicators (QI): QI-1 - number of improperly/misla-
belled BCT, QI-2 - number of inappropriate BCT 
(wrong BCT for the requested test), QI-3 - number 
of BCT with insufficient volume, QI-4 - number of 
BCT with inadequate sample-anticoagulant ratio, 
QI-5 - number of clotted samples, QI-6 - number of 
haemolysed samples and QI-7 - number of sam-
ples with lipaemia (elaborated in Supplementary 
Table 1) at the sample receiving area. Colour of the 
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serum or plasma obtained after centrifugation is 
visually inspected; pink or red colour is suggestive 
of haemolysis and turbid or white/creamy colour is 
suggestive of lipaemia. The BCT with any of the 
above mentioned preanalytical error(s) is rejected 
after informing the healthcare professional at the 
source site, and the information is recorded sys-
tematically. The samples with no errors are pro-
cessed and processing is followed by the technical 
validation of the generated results. 
Also, during the study period, a new laboratory in-
formation system (LIS) was introduced in July (e-
Hospital, developed by National Informatics Cen-
tre under the Digital India initiative of the Ministry 
of Electronics & Information Technology, Govern-
ment of India) in the clinical laboratory due to the 
termination of the hospital contract of the plat-
form being used earlier. In order to get acquainted 
with the user experience and design of the new 
platform, the laboratory staff and doctors under-
went three days training.
Statistical analysis
Data collected is descriptive and is represented in 
percentages. Data was analysed using Stata Statis-
tical Software, version 15 (StataCorp 2017, College 
Station, USA). Categorical variables were described 
using frequencies and percentages and the two 
groups were compared using the chi-square test. 
A value of P < 0.05 was considered statistically sig-
nificant.
Results 
Total of 107,716 blood specimens were screened of 
which 43,396 (40.3%) were received during the 
pandemic phase (Table 1). The blood specimen re-
jection rate during the pandemic phase was signif-
icantly higher than the pre-pandemic phase (3.0% 
versus 1.1%; P < 0.001). On monthly analysis, most 
errors in the pandemic phase occurred in the ini-
tial months, highest in April (17.2%) followed by 
May (10.2%) and least in October (1.8%) (Figure 1).
Characterisation of preanalytical errors
Most of the preanalytical errors in the pandemic 
phase were due to undesirable clotting of the sam-
ples (730/1324; 55.1%) which remained high during 
the entire period. Moreover, there was a significant 
increase in improperly labelled samples (P < 0.001), 
highest observed in the month of July. Samples 
with insufficient volume also increased significantly 
during the pandemic period (P < 0.001). A signifi-
cant decline in the samples with inadequate sam-
ple-anticoagulant ratio (P = 0.003) and haemolysed 
samples (P < 0.001) were observed (Table 1). 
Variables Pre-pandemic phase(N = 64,320)
Pandemic phase
(N = 43,396) P
Blood specimen rejection rate 1.1% 3.0% < 0.001
Total BCT rejected 735 1324 < 0.001
Proportion of BCT with individual preanalytical errors out of the total number received 
Improperly/mislabelled BCT 32/703 196/1128 < 0.001
Inappropriate BCT 10/725 24/1300 0.300
BCT with insufficient volume 22/713 244/1080 < 0.001
Inadequate sample-anticoagulant ratio 47/688 41/1283 0.003
Clotted samples 166/569 594/730 < 0.001
Haemolysed samples 215/520 89/1235 < 0.001
BCT - blood collection tube. Level of significance set at P < 0.05.
Table 1. Blood specimen rejection rate and characterisation of preanalytical errors in the pre-pandemic and the pandemic phases
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Discussion
The major finding of our study was that the speci-
men rejection rate during the pandemic phase 
was significantly higher than the pre-pandemic 
phase which was highest at the beginning of the 
pandemic and gradually declined towards the end 
of the study period. In contrast, the other pub-
lished studies which compare the preanalytical er-
rors occurring in the pre-pandemic and pandemic 
phase, have not shown any change in the frequen-
cy of preanalytical errors during the pandemic pe-
riod in their set-up (9,10). However, the overall re-
jection rate observed in our study was similar to 
pre-pandemic studies (11-15). 
The overall increased frequency of preanalytical 
errors is probably due to three reasons. Firstly, 
there was increase in the number of healthcare 
professionals handling patient specimens per day 
in the wards and intensive care units. This was due 
to shorter duration of duty shifts and frequent bi-
weekly/monthly rotation of healthcare profession-
als due to mandatory quarantine periods. Also the 
healthcare professionals involved in phlebotomy 
were from a mix of clinical and non-clinical spe-
cialties. The increased number and heterogeneity 
of healthcare professionals working in a day may 
have affected the quality of sampling. Secondly, 
the PPE worn by all healthcare personnel made 
specimen collection challenging. The decreased 
field of vision, reduced manual dexterity along 
with the heightened mental stress experienced 
while managing infectious patients are possible 
reasons for increase in some of the errors in the 
preanalytical phase (16-18). Lastly, the shortage of 
time for the healthcare professionals due to high 
patient load may also have affected specimen col-
lection process. Appointing a trained and dedicat-








Monthly frequency of preanalytical errors during pandemic period
specimens received
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ed team of phlebotomists may help to reduce pre-
analytical errors and relieve the burden on health-
care professionals involved in clinical care of the 
patients. 
The sharp increase in the frequency of preanalyti-
cal errors in the initial months of the pandemic fol-
lowed by its rapid decline, could be explained by 
the fact that a basic level of competency was 
achieved by the healthcare professionals as the 
pandemic continued, along with the decrease in 
fear and anxiety of the healthcare professionals 
while collecting and handling blood specimens.
In our study, clotted samples (QI-5) constituted the 
largest proportion of preanalytical errors both in 
the pre-pandemic and the pandemic phases, and 
continued to remain significantly high during the 
entire pandemic period. Clotting of blood in BCT 
with anticoagulants generally occurs either due to 
improper mixing after blood collection or due to 
improper blood-to-anticoagulant ratio. The under-
filled or over-filled citrated tubes with inappropri-
ate sample-anticoagulant ratio (QI-4) that may or 
may not have visible clots can affect test results 
and hence be detrimental to patient care (19). This 
study finding can be attributed probably to vary-
ing level of knowledge and awareness amongst 
the healthcare professionals regarding good phle-
botomy practices, and the number of inversions 
recommended to mix anticoagulant and blood 
properly. The added stress of focussing on main-
taining stringent infection control measures could 
also have resulted in increase in this error. 
In-vitro haemolysis (QI-6) is usually reported to be 
the commonest cause of preanalytical error in a 
clinical chemistry laboratory. In our study, it was 
the second most common error in the pre-pan-
demic period and the fourth most common error 
during the pandemic period. Undesirable haemol-
ysis may occur either due to high pressure of the 
piston during collecting and dispensing the blood 
in tubes or could be due to exposure to extreme 
temperature or vigorous shaking during transport 
(20). In the pre-pandemic phase, the blood sam-
ples were received mostly by pneumatic shoot, 
and rarely hand-delivered by a hospital attendant. 
Also, due to the urgency at the clinician’s end to 
fetch reports as quickly as possible, the hospital 
attendant transporting the specimens hurried to 
the laboratory, probably deviating from the speci-
men handling protocol during transport. However, 
at present, extra measures and safety protocols 
were implemented while handling blood speci-
mens of COVID-19 patients. The specimens are 
transported to the laboratory in bio-hazard zip-
lock bags placed inside dedicated blood transport 
box. This change of practice may have led to re-
duction in the frequency of haemolysed samples. 
Standardising the specimen transport protocol 
and its strict execution can probably help in re-
ducing this error even in the non-pandemic times 
in the future (21).
Samples with insufficient volumes (QI-3) formed a 
major proportion during the pandemic period and 
were significantly higher than the pre-pandemic 
phase. Generally, the major causes for receiving in-
sufficient quantity for testing are difficult access 
for venepuncture in patients with chronic debili-
tating diseases, patients on chemotherapy, pa-
tients in shock and in the paediatric population. 
The use of microtainers and micro-tubes to reduce 
the volume withdrawn for such patients may aid 
in reducing this error. Apart from the above rea-
sons, increased demand of serum based test pa-
rameters like procalcitonin, interleukin-6, ferritin 
and troponin-I could have resulted in increased 
samples with insufficient volume. Another reason 
could be that in the pre-pandemic period, the 
medical technologist used to de-cap the BCT to 
collect the serum in a separate cup and run it on 
manual mode in order to decrease the dead space 
in case of low sample volume. This was done to 
prevent repeat sampling and thereby avoid losing 
time during management of critically ill trauma 
patients. But presently, de-capping any BCT is not 
recommended in the laboratory, considering the 
risk of infection to the laboratory personnel.
The introduction of a new LIS, a new barcode gen-
erating system along with addition of new test 
profile during the second half of the pandemic 
phase (July 2020) in the hospital led to a significant 
increase in mislabelled samples (QI-1). The health-
care professionals at patient care sites took time to 
learn and use the new LIS, the new barcode labels 
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and their generation method. Some of the com-
mon errors observed during the initial introduc-
tion of the new LIS were generation of wrong bar 
codes in terms of wrong test selection, wrong pa-
tient selection or re-selection of an old barcode. 
This finding is a confounding factor in our study 
and could have been avoided if the same LIS had 
been in use throughout the study period.
The errors due to mislabelling of tubes affect pa-
tient identification, and may lead to patient identi-
ty mix-up. Recommendations for the correct pa-
tient and sample identification procedures should 
be strictly followed at the patient site and in the 
clinical laboratory (22).
The frequency of blood samples received in inap-
propriate BCT (QI-2) during both the phases were 
similar and reflects a general lack of knowledge 
among the healthcare professionals on the ration-
ale of using anti-coagulated and plain/serum-sep-
arator BCT (23).
It is evident from our study that during the pan-
demic, preanalytical errors have increased due to 
the changed logistics and therefore require more 
attention (Supplementary Table 2). Most can be 
addressed by training the healthcare professionals 
and by periodic reiteration by experts about the 
sample withdrawal technique, the order of draw, 
the number of inversions recommended to mix 
anticoagulant and blood properly, and the re-
quired standardised volume to be dispensed for 
each blood collection tube based on the available 
international guidelines (24-26). A special teaching 
module on ‘laboratory preparedness during a pan-
demic with a focus on preventing preanalytical er-
rors’ for healthcare professionals working outside 
and inside the laboratory should be designed and 
implemented. Better communication between 
laboratories and the healthcare professionals at 
patient care sites can definitely help in overcom-
ing the concerning issue of preanalytical errors. 
There were certain limitations to our study. The 
frequency and the distribution of preanalytical er-
rors observed in this study may vary at different 
centres. Since specimens were visually screened 
for preanalytical QIs, mild haemolysis or micro-
clots may may not have been recorded that may 
potentially change the proportion of errors. The 
introduction of a new LIS during the study period 
led to a significant increase in the mislabelled sam-
ples and is a confounding factor. 
Conclusion
Although the number of specimens received dur-
ing the pandemic period has declined, the fre-
quency of preanalytical errors and the resultant 
blood specimen rejection rate has risen signifi-
cantly in comparison to the pre-pandemic time. 
Our study highlights the need for corrective steps 
at various levels to reduce preanalytical errors 
which shall help to optimise patient care and re-
source utilisation. 
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